Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta …

CL Vale, D Fisher, A Kneebone, C Parker, M Pearse… - The Lancet, 2020 - thelancet.com
Background It is unclear whether adjuvant or early salvage radiotherapy following radical
prostatectomy is more appropriate for men who present with localised or locally advanced …

[HTML][HTML] Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification

ND Shore, JW Moul, KJ Pienta, J Czernin… - Prostate Cancer and …, 2023 - nature.com
Background Nearly one-third of patients with prostate cancer (PCa) experience biochemical
recurrence (BCR) after primary definitive treatment. BCR increases the risk of distant …

Clinically localized prostate cancer: AUA/ASTRO guideline, part I: introduction, risk assessment, staging, and risk-based management

JA Eastham, GB Auffenberg, DA Barocas… - The Journal of …, 2022 - auajournals.org
Purpose: The summary presented herein represents Part I of the three-part series dedicated
to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing risk assessment …

The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an …

A Pollack, TG Karrison, AG Balogh, LG Gomella… - The Lancet, 2022 - thelancet.com
Background In men with a detectable prostate-specific antigen (PSA) level after
prostatectomy for prostate cancer, salvage prostate bed radiotherapy (PBRT) results in …

Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non …

A Kneebone, C Fraser-Browne, GM Duchesne… - The Lancet …, 2020 - thelancet.com
Background Adjuvant radiotherapy has been shown to halve the risk of biochemical
progression for patients with high-risk disease after radical prostatectomy. Early salvage …

Clinically localized prostate cancer: AUA/ASTRO guideline, part II: principles of active surveillance, principles of surgery, and follow-up

JA Eastham, GB Auffenberg, DA Barocas… - Journal of …, 2022 - journals.lww.com
Purpose: The summary presented herein represents Part II of the three-part series dedicated
to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing principles of …

Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical …

P Sargos, S Chabaud, I Latorzeff, N Magné… - The Lancet …, 2020 - thelancet.com
Background Adjuvant radiotherapy reduces the risk of biochemical progression in prostate
cancer patients after radical prostatectomy. We aimed to compare adjuvant versus early …

[HTML][HTML] Management of patients with advanced prostate cancer. Part I: intermediate-/high-risk and locally advanced disease, biochemical relapse, and side effects of …

S Gillessen, A Bossi, ID Davis, J de Bono, K Fizazi… - European urology, 2023 - Elsevier
Background Innovations in imaging and molecular characterisation and the evolution of new
therapies have improved outcomes in advanced prostate cancer. Nonetheless, we continue …

18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre …

AB Jani, E Schreibmann, S Goyal, R Halkar… - The Lancet, 2021 - thelancet.com
Background Molecular imaging is increasingly used to guide treatment decisions and
planning in prostate cancer. We aimed to evaluate the role of 18 F-fluciclovine-PET/CT in …

Adjuvant versus early salvage radiation therapy for men at high risk for recurrence following radical prostatectomy for prostate cancer and the risk of death

D Tilki, MH Chen, J Wu, H Huland… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE Adjuvant compared with early salvage radiation therapy (sRT) following radical
prostatectomy (RP) has not been shown to reduce progression-free survival in randomized …